Vildalgliptin and Glucose Variability in Type 2 Diabetes

Trial Profile

Vildalgliptin and Glucose Variability in Type 2 Diabetes

Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2014

At a glance

  • Drugs Vildagliptin (Primary) ; Metformin; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 02 Jul 2014 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 07 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top